Should Medical Device Companies Make or Buy Their Growth?
Companies investing in R&D have created more value for shareholders over the past 10 years.
Companies investing in R&D have created more value for shareholders over the past 10 years.
ABOUT FORTUNA ADVISORS
Our team has advised hundreds of clients on developing a new approach to creating exceptional value for stakeholders and shareholders. Our differentiated cash-based earnings approach to strategic management and capital allocation draws on years of experience as advisors and investors at Credit Suisse, Morgan Stanley, Lehman Brothers, DLJ, Stern Stewart, Marakon, Ernst & Young, and ISS.
© 2021 FORTUNA ADVISORS – ALL RIGHTS RESERVED